Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension
Authors:
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 30 (7) , 1440-1443
Abstract
Background: Type 2 diabetes mellitus and hypertension are closely associated and contribute together to microvascular and macrovascular end-organ damage. Prevalence of hypertension is increased even in the prediabetic state. However, there is little information available about the relationship between incidence of hypertension and a deterioration of glucose tolerance from impaired glucose tolerance (IGT) to diabetes. Methods: To clarify these issues we analysed data from the Stop non insulin dependent diabetes mellitus (STOP-NIDDM) trial a prospective interventional study for the prevention of type 2 diabetes in people with prediabetes using the alpha-glucosidase inhibitor acarbose. Hypertension was already present at study entry in 702 (51.3%) of 1368 patients who were eligible for intention-to-treat analysis. Results: A total of 96 out of the 666 normotensive individuals at baseline developed hypertension during the 3.3-year follow-up. The strongest risk factors for time to development of hypertension were abdominal obesity at baseline [hazard ratio 1.91, 95% confidence interval (CI) 1.19-3.05, P<0.01] and worsening of glucose tolerance (hazard ratio 1.54, 95% CI 1.02-2.32, P<0.05), whereas acarbose treatment reduced the risk of hypertension (hazard ratio 0.59, 95% CI 0.39-0.90, P<0.05). Conclusion: A significant relationship was found between the development of type 2 diabetes and hypertension in patients with IGT, and treatment with acarbose, which primarily improved postprandial hyperglycaemia, reduced the incidence of hypertension as well as diabetes. This suggests that the two entities shared 'common soil'.Keywords
This publication has 25 references indexed in Scilit:
- Relationships Among Insulin Resistance, Type 2 Diabetes, Essential Hypertension, and Cardiovascular Disease: Similarities and DifferencesThe Journal of Clinical Hypertension, 2011
- Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsNew England Journal of Medicine, 2010
- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular EventsNew England Journal of Medicine, 2010
- Systolic Heart FailureNew England Journal of Medicine, 2010
- Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin InterventionDiabetes Care, 2009
- Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general populationJournal Of Hypertension, 2008
- Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) studyCardiovascular Diabetology, 2007
- Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α‐glucosidase inhibitor acarboseThe FASEB Journal, 2005
- Postprandial Glucose Regulation and Diabetic ComplicationsArchives of internal medicine (1960), 2004
- Post‐challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima‐media thickness: the RIAD StudyDiabetic Medicine, 2000